Patients’ considerations of time toxicity when assessing cancer treatments with marginal benefit
Article in The Oncologist (July 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Three-year follow-up study reveals improved survival rate in NSCLC patients underwent guideline-concordant diagnosis and treatment
Article in Frontiers in Oncology (May 2024)
Making Use of Technology to Improve Stated Preference Studies
Article in The Patient - Patient-Centered Outcomes Research (April 2024)